Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy

Authors: Eric W Brunskill, S Steven Potter

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Diabetic nephropathy is the leading cause of end stage renal disease. All three cell types of the glomerulus, podocytes, endothelial cells and mesangial cells, play important roles in diabetic nephropathy. In this report we used Meis1-GFP transgenic mice to purify mesangial cells from normal mice and from db/db mice, which suffer diabetic nephropathy. The purpose of the study is to better define the unique character of normal mesangial cells, and to characterize their pathogenic and protective responses during diabetic nephropathy.

Methods

Comprehensive gene expression states of the normal and diseased mesangial cells were defined with microarrays. By comparing the gene expression profiles of mesangial cells with those of multiple other renal cell types, including podocytes, endothelial cells and renal vesicles, it was possible to better define their exceptional nature, which includes smooth muscle, phagocytic and neuronal traits.

Results

The complete set of mesangial cell expressed transcription factors, growth factors and receptors were identified. In addition, the analysis of the mesangial cells from diabetic nephropathy mice characterized their changes in gene expression. Molecular functions and biological processes specific to diseased mesangial cells were characterized, identifying genes involved in extracellular matrix, cell division, vasculogenesis, and growth factor modulation. Selected gene changes considered of particular importance to the disease process were validated and localized within the glomuerulus by immunostaining. For example, thrombospondin, a key mediator of TGFβ signaling, was upregulated in the diabetic nephropathy mesangial cells, likely contributing to fibrosis. On the other hand the decorin gene was also upregulated, and expression of this gene has been strongly implicated in the reduction of TGFβ induced fibrosis.

Conclusions

The results provide an important complement to previous studies examining mesangial cells grown in culture. The remarkable qualities of the mesangial cell are more fully defined in both the normal and diabetic nephropathy diseased state. New gene expression changes and biological pathways are discovered, yielding a deeper understanding of the diabetic nephropathy pathogenic process, and identifying candidate targets for the development of novel therapies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Atkins RC, Zimmet P: Diabetic kidney disease: act now or pay later. Nephrol Dial Transplant. 2010, 25 (2): 331-333. 10.1093/ndt/gfp757.CrossRefPubMed Atkins RC, Zimmet P: Diabetic kidney disease: act now or pay later. Nephrol Dial Transplant. 2010, 25 (2): 331-333. 10.1093/ndt/gfp757.CrossRefPubMed
2.
go back to reference Steffes MW, Bilous RW, Sutherland DE, Mauer SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes. 1992, 41 (6): 679-684. 10.2337/diabetes.41.6.679.CrossRefPubMed Steffes MW, Bilous RW, Sutherland DE, Mauer SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes. 1992, 41 (6): 679-684. 10.2337/diabetes.41.6.679.CrossRefPubMed
3.
go back to reference Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H: Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int. 2003, 64 (5): 1632-1642. 10.1046/j.1523-1755.2003.00263.x.CrossRefPubMed Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H: Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int. 2003, 64 (5): 1632-1642. 10.1046/j.1523-1755.2003.00263.x.CrossRefPubMed
4.
go back to reference Hishikawa K, Oemar BS, Nakaki T: Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem. 2001, 276 (20): 16797-16803. 10.1074/jbc.M010722200.CrossRefPubMed Hishikawa K, Oemar BS, Nakaki T: Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem. 2001, 276 (20): 16797-16803. 10.1074/jbc.M010722200.CrossRefPubMed
5.
go back to reference Mishra R, Leahy P, Simonson MS: Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol. 2002, 283 (5): F1151-F1159.CrossRefPubMed Mishra R, Leahy P, Simonson MS: Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol. 2002, 283 (5): F1151-F1159.CrossRefPubMed
6.
go back to reference Yoshimura H, Sakai T, Kuwahara Y, Ito M, Tsuritani K, Hirasawa Y, Nagamatsu T: Effects of kynurenine metabolites on mesangial cell proliferation and gene expression. Exp Mol Pathol. 2009, 87 (1): 70-75. 10.1016/j.yexmp.2009.02.002.CrossRefPubMed Yoshimura H, Sakai T, Kuwahara Y, Ito M, Tsuritani K, Hirasawa Y, Nagamatsu T: Effects of kynurenine metabolites on mesangial cell proliferation and gene expression. Exp Mol Pathol. 2009, 87 (1): 70-75. 10.1016/j.yexmp.2009.02.002.CrossRefPubMed
7.
go back to reference Simonson MS, Ismail-Beigi F: Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J Biol Chem. 2011, 286 (13): 11003-11008. 10.1074/jbc.M110.190793.CrossRefPubMed Simonson MS, Ismail-Beigi F: Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J Biol Chem. 2011, 286 (13): 11003-11008. 10.1074/jbc.M110.190793.CrossRefPubMed
8.
go back to reference Sadlier DM, Ouyang X, McMahon B, Mu W, Ohashi R, Rodgers K, Murray D, Nakagawa T, Godson C, Doran P, et al: Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis. Kidney Int. 2005, 68 (6): 2542-2561. 10.1111/j.1523-1755.2005.00661.x.CrossRefPubMed Sadlier DM, Ouyang X, McMahon B, Mu W, Ohashi R, Rodgers K, Murray D, Nakagawa T, Godson C, Doran P, et al: Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis. Kidney Int. 2005, 68 (6): 2542-2561. 10.1111/j.1523-1755.2005.00661.x.CrossRefPubMed
9.
go back to reference Brunskill EW, Georgas K, Rumballe B, Little MH, Potter SS: Defining the molecular character of the developing and adult kidney podocyte. PLoS One. 2011, 6 (9): e24640-10.1371/journal.pone.0024640.CrossRefPubMedPubMedCentral Brunskill EW, Georgas K, Rumballe B, Little MH, Potter SS: Defining the molecular character of the developing and adult kidney podocyte. PLoS One. 2011, 6 (9): e24640-10.1371/journal.pone.0024640.CrossRefPubMedPubMedCentral
10.
go back to reference Brunskill EW, Aronow BJ, Georgas K, Rumballe B, Valerius MT, Aronow J, Kaimal V, Jegga AG, Yu J, Grimmond S, et al: Atlas of gene expression in the developing kidney at microanatomic resolution. Dev Cell. 2008, 15 (5): 781-791. 10.1016/j.devcel.2008.09.007.CrossRefPubMedPubMedCentral Brunskill EW, Aronow BJ, Georgas K, Rumballe B, Valerius MT, Aronow J, Kaimal V, Jegga AG, Yu J, Grimmond S, et al: Atlas of gene expression in the developing kidney at microanatomic resolution. Dev Cell. 2008, 15 (5): 781-791. 10.1016/j.devcel.2008.09.007.CrossRefPubMedPubMedCentral
11.
go back to reference Chen J, Bardes EE, Aronow BJ, Jegga AG: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009, 37 (Web Server issue): W305-W311.CrossRefPubMedPubMedCentral Chen J, Bardes EE, Aronow BJ, Jegga AG: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009, 37 (Web Server issue): W305-W311.CrossRefPubMedPubMedCentral
12.
go back to reference Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ: ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res. 2010, 38 (Web Server issue): W96-W102.CrossRefPubMedPubMedCentral Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ: ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res. 2010, 38 (Web Server issue): W96-W102.CrossRefPubMedPubMedCentral
13.
go back to reference Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13 (11): 2498-2504. 10.1101/gr.1239303.CrossRefPubMedPubMedCentral Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13 (11): 2498-2504. 10.1101/gr.1239303.CrossRefPubMedPubMedCentral
14.
go back to reference Hernandez AM, Villamar M, Rosello L, Moreno-Pelayo MA, Moreno F, Del Castillo I: Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations. Am J Med Genet A. 2007, 143 (7): 757-762.CrossRef Hernandez AM, Villamar M, Rosello L, Moreno-Pelayo MA, Moreno F, Del Castillo I: Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations. Am J Med Genet A. 2007, 143 (7): 757-762.CrossRef
15.
go back to reference Wieser R: The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene. 2007, 396 (2): 346-357. 10.1016/j.gene.2007.04.012.CrossRefPubMed Wieser R: The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene. 2007, 396 (2): 346-357. 10.1016/j.gene.2007.04.012.CrossRefPubMed
16.
go back to reference Gurumurthy S, Rangnekar VM: Par-4 inducible apoptosis in prostate cancer cells. J Cell Biochem. 2004, 91 (3): 504-512. 10.1002/jcb.20000.CrossRefPubMed Gurumurthy S, Rangnekar VM: Par-4 inducible apoptosis in prostate cancer cells. J Cell Biochem. 2004, 91 (3): 504-512. 10.1002/jcb.20000.CrossRefPubMed
17.
go back to reference Xie J, Guo Q: PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein. J Biol Chem. 2005, 280 (14): 13824-13832. 10.1074/jbc.M411933200.CrossRefPubMed Xie J, Guo Q: PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein. J Biol Chem. 2005, 280 (14): 13824-13832. 10.1074/jbc.M411933200.CrossRefPubMed
18.
go back to reference Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, et al: A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol. 1996, 16 (12): 6945-6956.CrossRefPubMedPubMedCentral Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, et al: A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol. 1996, 16 (12): 6945-6956.CrossRefPubMedPubMedCentral
19.
go back to reference Guenette SY, Chen J, Jondro PD, Tanzi RE: Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Proc Natl Acad Sci U S A. 1996, 93 (20): 10832-10837. 10.1073/pnas.93.20.10832.CrossRefPubMedPubMedCentral Guenette SY, Chen J, Jondro PD, Tanzi RE: Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Proc Natl Acad Sci U S A. 1996, 93 (20): 10832-10837. 10.1073/pnas.93.20.10832.CrossRefPubMedPubMedCentral
20.
go back to reference Lange A, Thon L, Mathieu S, Adam D: The apoptosis inhibitory domain of FE65-like protein 1 regulates both apoptotic and caspase-independent programmed cell death mediated by tumor necrosis factor. Biochem Biophys Res Commun. 2005, 335 (2): 575-583. 10.1016/j.bbrc.2005.07.125.CrossRefPubMed Lange A, Thon L, Mathieu S, Adam D: The apoptosis inhibitory domain of FE65-like protein 1 regulates both apoptotic and caspase-independent programmed cell death mediated by tumor necrosis factor. Biochem Biophys Res Commun. 2005, 335 (2): 575-583. 10.1016/j.bbrc.2005.07.125.CrossRefPubMed
21.
go back to reference Watanabe M, Layne MD, Hsieh CM, Maemura K, Gray S, Lee ME, Jain MK: Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta. Circ Res. 2002, 91 (5): 382-389. 10.1161/01.RES.0000033593.05545.7B.CrossRefPubMed Watanabe M, Layne MD, Hsieh CM, Maemura K, Gray S, Lee ME, Jain MK: Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta. Circ Res. 2002, 91 (5): 382-389. 10.1161/01.RES.0000033593.05545.7B.CrossRefPubMed
22.
go back to reference Schmahl J, Raymond CS, Soriano P: PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet. 2007, 39 (1): 52-60. 10.1038/ng1922.CrossRefPubMed Schmahl J, Raymond CS, Soriano P: PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet. 2007, 39 (1): 52-60. 10.1038/ng1922.CrossRefPubMed
23.
go back to reference Chen F, Kook H, Milewski R, Gitler AD, Lu MM, Li J, Nazarian R, Schnepp R, Jen K, Biben C, et al: Hop is an unusual homeobox gene that modulates cardiac development. Cell. 2002, 110 (6): 713-723. 10.1016/S0092-8674(02)00932-7.CrossRefPubMed Chen F, Kook H, Milewski R, Gitler AD, Lu MM, Li J, Nazarian R, Schnepp R, Jen K, Biben C, et al: Hop is an unusual homeobox gene that modulates cardiac development. Cell. 2002, 110 (6): 713-723. 10.1016/S0092-8674(02)00932-7.CrossRefPubMed
24.
go back to reference Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, et al: E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes. 2010, 59 (7): 1794-1802. 10.2337/db09-1736.CrossRefPubMedPubMedCentral Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, et al: E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes. 2010, 59 (7): 1794-1802. 10.2337/db09-1736.CrossRefPubMedPubMedCentral
25.
go back to reference Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A: Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med. 2007, 204 (12): 2935-2948. 10.1084/jem.20071082.CrossRefPubMedPubMedCentral Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A: Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med. 2007, 204 (12): 2935-2948. 10.1084/jem.20071082.CrossRefPubMedPubMedCentral
26.
go back to reference Russell L, Garrett-Sinha LA: Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine. 2010, 51 (3): 217-226. 10.1016/j.cyto.2010.03.006.CrossRefPubMed Russell L, Garrett-Sinha LA: Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine. 2010, 51 (3): 217-226. 10.1016/j.cyto.2010.03.006.CrossRefPubMed
27.
go back to reference Orr B, Vanpoucke G, Grace OC, Smith L, Anderson RA, Riddick AC, Franco OE, Hayward SW, Thomson AA: Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Prostate. 2011, 71 (3): 305-317. 10.1002/pros.21244.CrossRefPubMed Orr B, Vanpoucke G, Grace OC, Smith L, Anderson RA, Riddick AC, Franco OE, Hayward SW, Thomson AA: Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Prostate. 2011, 71 (3): 305-317. 10.1002/pros.21244.CrossRefPubMed
28.
go back to reference Perez-Pinera P, Alcantara S, Dimitrov T, Vega JA, Deuel TF: Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2006, 103 (47): 17795-17800. 10.1073/pnas.0607299103.CrossRefPubMedPubMedCentral Perez-Pinera P, Alcantara S, Dimitrov T, Vega JA, Deuel TF: Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2006, 103 (47): 17795-17800. 10.1073/pnas.0607299103.CrossRefPubMedPubMedCentral
29.
go back to reference Svensson SL, Pasupuleti M, Walse B, Malmsten M, Morgelin M, Sjogren C, Olin AI, Collin M, Schmidtchen A, Palmer R, et al: Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem. 2010, 285 (21): 16105-16115. 10.1074/jbc.M109.081232.CrossRefPubMedPubMedCentral Svensson SL, Pasupuleti M, Walse B, Malmsten M, Morgelin M, Sjogren C, Olin AI, Collin M, Schmidtchen A, Palmer R, et al: Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem. 2010, 285 (21): 16105-16115. 10.1074/jbc.M109.081232.CrossRefPubMedPubMedCentral
30.
go back to reference Raymond A, Ensslin MA, Shur BD: SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions. J Cell Biochem. 2009, 106 (6): 957-966. 10.1002/jcb.22076.CrossRefPubMedPubMedCentral Raymond A, Ensslin MA, Shur BD: SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions. J Cell Biochem. 2009, 106 (6): 957-966. 10.1002/jcb.22076.CrossRefPubMedPubMedCentral
31.
go back to reference Motegi S, Leitner WW, Lu M, Tada Y, Sardy M, Wu C, Chavakis T, Udey MC: Pericyte-derived MFG-E8 regulates pathologic angiogenesis. Arterioscler Thromb Vasc Biol. 2011, 31 (9): 2024-2034. 10.1161/ATVBAHA.111.232587.CrossRefPubMedPubMedCentral Motegi S, Leitner WW, Lu M, Tada Y, Sardy M, Wu C, Chavakis T, Udey MC: Pericyte-derived MFG-E8 regulates pathologic angiogenesis. Arterioscler Thromb Vasc Biol. 2011, 31 (9): 2024-2034. 10.1161/ATVBAHA.111.232587.CrossRefPubMedPubMedCentral
32.
go back to reference Motegi S, Garfield S, Feng X, Sardy M, Udey MC: Potentiation of platelet-derived growth factor receptor-beta signaling mediated by integrin-associated MFG-E8. Arterioscler Thromb Vasc Biol. 2011, 31 (11): 2653-2664. 10.1161/ATVBAHA.111.233619.CrossRefPubMed Motegi S, Garfield S, Feng X, Sardy M, Udey MC: Potentiation of platelet-derived growth factor receptor-beta signaling mediated by integrin-associated MFG-E8. Arterioscler Thromb Vasc Biol. 2011, 31 (11): 2653-2664. 10.1161/ATVBAHA.111.233619.CrossRefPubMed
33.
go back to reference Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM: Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol. 1998, 274 (1 Pt 2): F43-F50.PubMed Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM: Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol. 1998, 274 (1 Pt 2): F43-F50.PubMed
34.
go back to reference Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994, 8 (16): 1888-1896. 10.1101/gad.8.16.1888.CrossRefPubMed Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994, 8 (16): 1888-1896. 10.1101/gad.8.16.1888.CrossRefPubMed
35.
go back to reference Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G, Levkau B: Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res. 2011, 108 (3): 314-323. 10.1161/CIRCRESAHA.110.235028.CrossRefPubMed Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G, Levkau B: Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res. 2011, 108 (3): 314-323. 10.1161/CIRCRESAHA.110.235028.CrossRefPubMed
36.
go back to reference Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, Hirano K, Usui S, Wang F, Du W, et al: S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res. 2010, 85 (3): 484-493. 10.1093/cvr/cvp312.CrossRefPubMed Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, Hirano K, Usui S, Wang F, Du W, et al: S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res. 2010, 85 (3): 484-493. 10.1093/cvr/cvp312.CrossRefPubMed
37.
go back to reference Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG: Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol. 2007, 18 (6): 1732-1739. 10.1681/ASN.2006060634.CrossRefPubMed Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG: Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol. 2007, 18 (6): 1732-1739. 10.1681/ASN.2006060634.CrossRefPubMed
38.
go back to reference Sharma K, McCue P, Dunn SR: Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol. 2003, 284 (6): F1138-F1144.CrossRefPubMed Sharma K, McCue P, Dunn SR: Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol. 2003, 284 (6): F1138-F1144.CrossRefPubMed
39.
go back to reference Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest. 1998, 101 (5): 982-992. 10.1172/JCI1684.CrossRefPubMedPubMedCentral Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest. 1998, 101 (5): 982-992. 10.1172/JCI1684.CrossRefPubMedPubMedCentral
40.
go back to reference Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998, 93 (7): 1159-1170. 10.1016/S0092-8674(00)81460-9.CrossRefPubMed Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998, 93 (7): 1159-1170. 10.1016/S0092-8674(00)81460-9.CrossRefPubMed
41.
go back to reference Ziyadeh FN: Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol. 2004, 15 (Suppl 1): S55-S57.CrossRefPubMed Ziyadeh FN: Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol. 2004, 15 (Suppl 1): S55-S57.CrossRefPubMed
42.
go back to reference Raugi GJ, Lovett DH: Thrombospondin secretion by cultured human glomerular mesangial cells. Am J Pathol. 1987, 129 (2): 364-372.PubMedPubMedCentral Raugi GJ, Lovett DH: Thrombospondin secretion by cultured human glomerular mesangial cells. Am J Pathol. 1987, 129 (2): 364-372.PubMedPubMedCentral
43.
go back to reference Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM: Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia. 2005, 48 (12): 2650-2660. 10.1007/s00125-005-0006-5.CrossRefPubMed Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM: Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia. 2005, 48 (12): 2650-2660. 10.1007/s00125-005-0006-5.CrossRefPubMed
44.
go back to reference Adler SG, Feld S, Striker L, Striker G, LaPage J, Esposito C, Aboulhosn J, Barba L, Cha DR, Nast CC: Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int. 2000, 57 (5): 2084-2092. 10.1046/j.1523-1755.2000.00058.x.CrossRefPubMed Adler SG, Feld S, Striker L, Striker G, LaPage J, Esposito C, Aboulhosn J, Barba L, Cha DR, Nast CC: Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int. 2000, 57 (5): 2084-2092. 10.1046/j.1523-1755.2000.00058.x.CrossRefPubMed
45.
go back to reference Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes. 1995, 44 (8): 929-935. 10.2337/diabetes.44.8.929.CrossRefPubMed Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes. 1995, 44 (8): 929-935. 10.2337/diabetes.44.8.929.CrossRefPubMed
46.
go back to reference Lam S, van der Geest RN, Verhagen NA, Daha MR, van Kooten C: Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Nephrol Dial Transplant. 2004, 19 (7): 1694-1701. 10.1093/ndt/gfh235.CrossRefPubMed Lam S, van der Geest RN, Verhagen NA, Daha MR, van Kooten C: Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Nephrol Dial Transplant. 2004, 19 (7): 1694-1701. 10.1093/ndt/gfh235.CrossRefPubMed
47.
go back to reference Whiteside CI, Dlugosz JA: Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol. 2002, 282 (6): F975-F980.CrossRefPubMed Whiteside CI, Dlugosz JA: Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol. 2002, 282 (6): F975-F980.CrossRefPubMed
48.
go back to reference Kinoshita M, Nakamura T, Ihara M, Haraguchi T, Hiraoka Y, Tashiro K, Noda M: Identification of human endomucin-1 and −2 as membrane-bound O-sialoglycoproteins with anti-adhesive activity. FEBS Lett. 2001, 499 (1–2): 121-126.CrossRefPubMed Kinoshita M, Nakamura T, Ihara M, Haraguchi T, Hiraoka Y, Tashiro K, Noda M: Identification of human endomucin-1 and −2 as membrane-bound O-sialoglycoproteins with anti-adhesive activity. FEBS Lett. 2001, 499 (1–2): 121-126.CrossRefPubMed
49.
go back to reference Larsson M, Majeed M, Ernst JD, Magnusson KE, Stendahl O, Forsum U: Role of annexins in endocytosis of antigens in immature human dendritic cells. Immunology. 1997, 92 (4): 501-511. 10.1046/j.1365-2567.1997.00377.x.CrossRefPubMedPubMedCentral Larsson M, Majeed M, Ernst JD, Magnusson KE, Stendahl O, Forsum U: Role of annexins in endocytosis of antigens in immature human dendritic cells. Immunology. 1997, 92 (4): 501-511. 10.1046/j.1365-2567.1997.00377.x.CrossRefPubMedPubMedCentral
50.
go back to reference Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S: Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun. 2005, 337 (4): 1283-1287. 10.1016/j.bbrc.2005.10.004.CrossRefPubMed Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S: Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun. 2005, 337 (4): 1283-1287. 10.1016/j.bbrc.2005.10.004.CrossRefPubMed
51.
go back to reference Pu L, Fan JM: Effects of pioglitazone on the transdifferentiation and CTGF expression of renal tubular epithelial-myofibroblast in vitro. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010, 41 (1): 15-19.PubMed Pu L, Fan JM: Effects of pioglitazone on the transdifferentiation and CTGF expression of renal tubular epithelial-myofibroblast in vitro. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010, 41 (1): 15-19.PubMed
52.
go back to reference Ferdous Z, Wei VM, Iozzo R, Hook M, Grande-Allen KJ: Decorin-transforming growth factor- interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J Biol Chem. 2007, 282 (49): 35887-35898. 10.1074/jbc.M705180200.CrossRefPubMed Ferdous Z, Wei VM, Iozzo R, Hook M, Grande-Allen KJ: Decorin-transforming growth factor- interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J Biol Chem. 2007, 282 (49): 35887-35898. 10.1074/jbc.M705180200.CrossRefPubMed
53.
go back to reference Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S: Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res. 2010, 91 (2): 238-245. 10.1016/j.exer.2010.05.013.CrossRefPubMedPubMedCentral Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S: Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res. 2010, 91 (2): 238-245. 10.1016/j.exer.2010.05.013.CrossRefPubMedPubMedCentral
54.
go back to reference Williams KJ, Qiu G, Usui HK, Dunn SR, McCue P, Bottinger E, Iozzo RV, Sharma K: Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol. 2007, 171 (5): 1441-1450. 10.2353/ajpath.2007.070079.CrossRefPubMedPubMedCentral Williams KJ, Qiu G, Usui HK, Dunn SR, McCue P, Bottinger E, Iozzo RV, Sharma K: Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol. 2007, 171 (5): 1441-1450. 10.2353/ajpath.2007.070079.CrossRefPubMedPubMedCentral
Metadata
Title
Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy
Authors
Eric W Brunskill
S Steven Potter
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-70

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine